EXAS · As filed with the SEC

Exact Sciences balance sheet, by fiscal year

The statement as Exact Sciences presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Balance Sheets · USD thousands

USD thousands	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2021 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018
ASSETS
Current assets:
Cash and cash equivalents	955,996	600,889	605,378	242,493	315,471	1,491,288	177,254	160,430
Marketable securities	8,715	437,137	172,266	389,564	715,005	348,699	146,401	963,752
Accounts receivable, net	298,653	248,968	203,623	158,043	216,645	233,185	130,667	44,239
Inventory	166,201	162,383	127,475	118,259	104,994	92,265	61,724	39,148
Prepaid expenses and other current assets	126,284	122,046	85,627	73,898	74,122	33,157	40,913	20,498
Total current assets	1,555,849	1,571,423	1,194,369	982,257	1,426,237	2,198,594	556,959	1,228,067
Long-term assets:
Property, plant and equipment, net	708,664	693,673	698,354	684,756	580,248	450,683	455,325	245,259
Goodwill and intangibles, net	—	—	—	—	—	—	—	46,281,000
Operating lease right-of-use assets	122,332	116,952	143,708	167,003	174,225	125,947	126,444	—
Goodwill	2,368,048	2,366,676	2,367,120	2,346,040	2,335,172	1,237,672	1,203,197	—
Intangible assets, net	919,925	1,009,693	1,890,396	1,956,240	2,094,411	848,426	1,143,550	—
Other long-term assets, net	185,811	169,722	177,387	90,577	74,591	63,770	20,293	4,415
Total assets	5,860,629	5,928,139	6,471,334	6,226,873	6,684,884	4,925,092	3,505,768	1,524,022
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	175,868	89,572	78,816	74,916	67,829	35,709	25,973	28,141
Accrued liabilities	416,473	328,292	341,683	299,216	398,556	233,604	193,329	100,644
Accrued interest	—	—	—	—	—	—	—	4,593,000
Operating lease liabilities, current portion	33,591	27,405	29,379	28,366	19,710	11,483	7,891	—
Debt, current portion	—	—	—	—	—	—	834	8
Other current liabilities	15,220	37,765	14,823	10,249	30,973	38,265	8,467	3,204
Loans Payable, Current	—	0	50,000	—	—	—	—	—
Convertible Notes Payable, Current	0	249,153	—	—	0	255,464	—	—
Debt, current portion	—	—	—	—	0	1,319	—	—
Total current liabilities	641,152	732,187	514,701	412,747	517,068	575,844	236,494	136,590
Convertible notes, net	—	—	—	—	—	—	—	664,749,000
Convertible notes, net	—	—	—	—	—	—	803,605	—
Long-term debt, less current portion	—	—	—	—	—	—	24,032	24,073
Convertible notes, net, less current portion	2,327,177	2,321,067	2,314,276	2,186,106	2,180,232	1,320,760	—	—
Long-term debt, less current portion	—	—	0	50,000	0	22,342	—	—
Other long-term liabilities	329,317	315,503	335,982	352,459	417,782	61,582	34,911	9,475
Lease incentive obligation, less current portion	—	—	—	—	—	—	—	8,194,000
Operating lease liabilities, less current portion	161,931	157,133	161,070	182,399	182,166	121,075	118,665	—
Total liabilities	3,459,577	3,525,890	3,326,029	3,183,711	3,297,248	2,101,603	1,217,707	843,081
Stockholders’ equity:
Preferred stock, $0.01 par value Authorized—5,000,000 shares issued and outstanding—no shares at December 31, 2025 and December 31, 2024	0	0	0	0	0	0	0	—
Common stock, $0.01 par value Authorized—400,000,000 shares issued and outstanding—190,802,322 and 185,616,438 shares at December 31, 2025 and December 31, 2024	1,909	1,857	1,815	1,780	1,738	1,595	1,477	1,232
Additional paid-in capital	7,102,766	6,899,368	6,611,237	6,311,644	6,028,861	4,789,657	3,406,440	1,716,894
Accumulated other comprehensive income (loss)	2,358	(944)	1,428	(5,236)	(1,443)	526	(100)	(1,422)
Accumulated deficit	(4,705,981)	(4,498,032)	(3,469,175)	(3,265,026)	(2,641,520)	(1,968,289)	(1,119,756)	(1,035,763)
Total stockholders’ equity	2,401,052	2,402,249	3,145,305	3,043,162	3,387,636	2,823,489	2,288,061	680,941
Total liabilities and stockholders’ equity	5,860,629	5,928,139	6,471,334	6,226,873	6,684,884	4,925,092	3,505,768	1,524,022

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.